JBD prioritizes structured metadata and DOI registration so diabetes bioinformatics research is discoverable across scholarly platforms. Indexing helps findings reach researchers, clinicians, and data science teams who rely on validated evidence.

Our production workflow includes metadata validation and citation checks to improve discoverability and long term accuracy.

JBD maintains core identifiers and metadata services that support reliable citation, cataloging, and discovery across platforms.

• ISSN registration for consistent journal identification
• DOI assignment and metadata registration via Crossref
• Google Scholar discoverability subject to inclusion and crawling guidelines
• OAI-PMH endpoint for metadata harvesting: https://openaccesspub.org/oai (oai_dc)

• Accurate author names, affiliations, and ORCID identifiers
• Funding sources, grant numbers, and conflict disclosures
• Structured abstracts with clear objectives and results
• Domain specific keywords for diabetes bioinformatics
• Complete references with DOIs where available

Authors help improve discoverability by providing complete metadata, accurate references, and clear funding statements. Well structured abstracts and keywords improve visibility for diabetes and bioinformatics audiences.

• Include ORCID identifiers where available
• Use standardized disease and phenotype terminology
• Provide data repository links and accession numbers
• Ensure citations match reference lists

• Provide ORCID identifiers for all authors to strengthen metadata matching.
• Use standardized diabetes keywords and MeSH terms where applicable.
• Include funding agency names and grant numbers for metadata completeness.
• Check that author affiliations include institution names and country information.
• Confirm DOI links are accurate and resolve correctly.
• Ensure references include year, volume, issue, and page ranges.
• Avoid inconsistent journal abbreviations in reference lists.
• List data repository citations separately when required by the repository.
• Provide corresponding author email for indexing contact.
• Use structured abstracts with clear objectives and outcomes.
• Add clinical trial identifiers when relevant.
• Verify keywords reflect both bioinformatics and diabetes terms.
• Ensure article titles are descriptive and avoid unexplained acronyms.
• Provide clear funding statements to support discovery and compliance.
• Use consistent author name formatting across manuscript and metadata.
• Check that supplementary files are referenced in the metadata.
• Use consistent capitalization for gene symbols and abbreviations in titles.
• Check that corresponding author address includes country and postal code.
• Provide data availability keywords to support repository linking.
• Avoid special characters in article titles that can break metadata ingestion.
• Ensure supplementary material titles are descriptive and numbered.
• Use consistent date formats for clinical study timelines.
• Confirm that acknowledgements include data contributors or consortiums.
• Provide version numbers for datasets when citing database releases.
• Check for duplicate references or missing citations.

JBD is committed to rigorous, transparent publishing in bioinformatics and diabetes research. We emphasize reproducible computational methods, clear data provenance, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in computational and translational diabetes research.